Product Resource: Technology News

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research
| 4 min read

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research